Literature DB >> 30466924

Relation of selenium status to neuro-regeneration after traumatic spinal cord injury.

Raban Arved Heller1, Julian Seelig2, Tobias Bock1, Patrick Haubruck1, Paul Alfred Grützner3, Lutz Schomburg4, Arash Moghaddam1, Bahram Biglari5.   

Abstract

INTRODUCTION: The trace element selenium (Se) is crucial for the biosynthesis of selenoproteins. Both neurodevelopment and the survival of neurons that are subject to stress depend on a regular selenoprotein biosynthesis and sufficient Se supply by selenoprotein P (SELENOP). HYPOTHESIS: Neuro-regeneration after traumatic spinal cord injury (TSCI) is related to the Se status. STUDY
DESIGN: Single-centre prospective observational study. PATIENTS AND METHODS: Three groups of patients with comparable injuries were studied; vertebral fractures without neurological impairment (n = 10, group C), patients with TSCI showing no remission (n = 9, group G0), and patients with remission developing positive abbreviated injury score (AIS) conversion within 3 months (n = 10, group G1). Serum samples were available from different time points (upon admission, and after 4, 9 and 12 h, 1 and 3 days, 1 and 2 weeks, and 1, 2 and 3 months). Serum trace element concentrations were determined by total reflection X-ray fluorescence, SELENOP by ELISA, and further parameters by laboratory routine.
RESULTS: Serum Se and SELENOP concentrations were higher on admission in the remission group (G1) as compared to G0. During the first week, both parameters remained constant in C and G0, whereas they declined significantly in the remission group. Similarly, the concentration changes between admission and 24 h were most pronounced in this group of recovering patients (G1). Binary logistic regression analysis including the delta of Se and SELENOP within the first 24 h indicated an AUC of 90.0% (CI: 67.4%-100.0%) with regards to predicting the outcome after TSCI.
CONCLUSION: A Se deficit might constitute a risk factor for poor outcome after TSCI. A dynamic decline of serum Se and SELENOP concentrations after admission may reflect ongoing repair processes that are associated with higher odds for a positive clinical outcome.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Biomarker; Brain; ELISA; Inflammation; Injury; Neurodegeneration; Neuron; Paraplegia; Precision medicine; Prediction; Profile; Recovery; Selenoprotein P; Supplementation; Surgery; Trace element; Zinc

Mesh:

Substances:

Year:  2018        PMID: 30466924     DOI: 10.1016/j.jtemb.2018.10.006

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  7 in total

1.  Turning gray selenium into a nanoaccelerator of tissue regeneration by PEG modification.

Authors:  Jieqiong Cao; Yibo Zhang; Peiguang Zhang; Zilei Zhang; Bihui Zhang; Yanxian Feng; Zhixin Li; Yiqi Yang; Qilin Meng; Liu He; Yulin Cai; Zhenyu Wang; Jie Li; Xue Chen; Hongwei Liu; An Hong; Wenjie Zheng; Xiaojia Chen
Journal:  Bioact Mater       Date:  2022-01-02

2.  Epigallocatechin-3-gallate selenium nanoparticles for neuroprotection by scavenging reactive oxygen species and reducing inflammation.

Authors:  Yiming Wang; Wenqi Luo; Feng Lin; Wanguo Liu; Rui Gu
Journal:  Front Bioeng Biotechnol       Date:  2022-09-08

3.  Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury.

Authors:  Julian Seelig; Raban Arved Heller; Patrick Haubruck; Qian Sun; Jochen Georg Klingenberg; Julian Hackler; Helena Lucia Crowell; Volker Daniel; Arash Moghaddam; Lutz Schomburg; Bahram Biglari
Journal:  Front Neurosci       Date:  2021-05-28       Impact factor: 4.677

4.  Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite.

Authors:  Ola Brodin; Julian Hackler; Sougat Misra; Sebastian Wendt; Qian Sun; Elena Laaf; Christian Stoppe; Mikael Björnstedt; Lutz Schomburg
Journal:  Nutrients       Date:  2020-04-12       Impact factor: 5.717

5.  Zinc Concentration Dynamics Indicate Neurological Impairment Odds after Traumatic Spinal Cord Injury.

Authors:  Raban Arved Heller; André Sperl; Julian Seelig; Patrick Haubruck; Tobias Bock; Theresa Werner; Albert Besseling; Qian Sun; Lutz Schomburg; Arash Moghaddam; Bahram Biglari
Journal:  Antioxidants (Basel)       Date:  2020-05-13

6.  Products of Sulfide/Selenite Interaction Possess Antioxidant Properties, Scavenge Superoxide-Derived Radicals, React with DNA, and Modulate Blood Pressure and Tension of Isolated Thoracic Aorta.

Authors:  Marian Grman; Anton Misak; Lucia Kurakova; Vlasta Brezova; Sona Cacanyiova; Andrea Berenyiova; Peter Balis; Lenka Tomasova; Ammar Kharma; Enrique Domínguez-Álvarez; Miroslav Chovanec; Karol Ondrias
Journal:  Oxid Med Cell Longev       Date:  2019-11-25       Impact factor: 6.543

7.  Profile of gut microbiota in patients with traumatic thoracic spinal cord injury and its clinical implications: a case-control study in a rehabilitation setting.

Authors:  Binbin Yu; Huaide Qiu; Shupeng Cheng; Feng Ye; Jiahui Li; Sijing Chen; Li Zhou; Yumei Yang; Caiyun Zhong; Jianan Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.